Dr. Reddy's Laboratories Atorvastatin Calcium Tablets Recall

Why it was recalled

Failed Impurities/Degradation Specifications

Product description

Atorvastatin Calcium Tablets, 10 mg*, 90-count bottle, Rx Only, Mfd. By: Dr. Reddy's Laboratories Limited, Srikakulam - 532 409 INDIA, NDC 55111-121-90

Lot numbers, UPCs & expiration codes

Lot #: T600327, Exp 07/18; T700213, T700215, Exp 04/19

Where it was sold

Nationwide in the USA and Puerto Rico

What to do if you have this product

Compare the lot number and expiration date on your package with the codes above.
Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
If you have symptoms you think are related, contact your doctor. In an emergency call 911.
Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number: D-0886-2018
Classification: Class III
Status: Terminated
Recall initiated: Jun 12, 2018
FDA report date: Jun 27, 2018
Quantity: 55,126 bottles
Recall type: Voluntary: Firm initiated
Recalling firm: Dr. Reddy's Laboratories, Inc.

Original FDA data

Every field from FDA enforcement report D-0886-2018, exactly as published.

Show all FDA fields

City: Princeton
State: NJ
Status: Terminated
Country: United States
Event ID: 80275
Address: 107 College Rd E
Code information: Lot #: T600327, Exp 07/18; T700213, T700215, Exp 04/19
Postal code: 08540-6623
Report date: Jun 27, 2018
Product type: Drugs
Recall number: D-0886-2018
Classification: Class III
Recalling firm: Dr. Reddy's Laboratories, Inc.
Product quantity: 55,126 bottles
Termination date: Nov 8, 2019
Reason for recall: Failed Impurities/Degradation Specifications
Voluntary / mandated: Voluntary: Firm initiated
Product description: Atorvastatin Calcium Tablets, 10 mg*, 90-count bottle, Rx Only, Mfd. By: Dr. Reddy's Laboratories Limited, Srikakulam - 532 409 INDIA, NDC 55111-121-90
Distribution pattern: Nationwide in the USA and Puerto Rico
Recall initiation date: Jun 12, 2018
Initial firm notification: Letter
Center classification date: Jun 21, 2018

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0886-2018, published Jun 27, 2018. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: Oct 2, 2026. Content last changed: Oct 2, 2026.

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.